Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.

Behar DM, Rosset S, Tzur S, Selig S, Yudkovsky G, Bercovici S, Kopp JB, Winkler CA, Nelson GW, Wasser WG, Skorecki K.

Hum Mol Genet. 2010 May 1;19(9):1816-27. doi: 10.1093/hmg/ddq040.

2.

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K.

Hum Genet. 2010 Sep;128(3):345-50. doi: 10.1007/s00439-010-0861-0.

3.

Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.

Nelson GW, Freedman BI, Bowden DW, Langefeld CD, An P, Hicks PJ, Bostrom MA, Johnson RC, Kopp JB, Winkler CA.

Hum Mol Genet. 2010 May 1;19(9):1805-15. doi: 10.1093/hmg/ddq039.

4.

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.

Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW.

PLoS Genet. 2011 Jun;7(6):e1002150. doi: 10.1371/journal.pgen.1002150.

5.

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA.

Nat Genet. 2008 Oct;40(10):1175-84. doi: 10.1038/ng.226.

6.

Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.

Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW.

Nephrol Dial Transplant. 2009 Nov;24(11):3366-71. doi: 10.1093/ndt/gfp316.

7.

Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.

Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW, Freedman BI.

Kidney Int. 2011 Dec;80(12):1339-43. doi: 10.1038/ki.2011.286.

8.

Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.

Palmer ND, Ng MC, Hicks PJ, Mudgal P, Langefeld CD, Freedman BI, Bowden DW.

PLoS One. 2014 Feb 13;9(2):e88273. doi: 10.1371/journal.pone.0088273.

9.

Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.

Hawkins GA, Friedman DJ, Lu L, McWilliams DR, Chou JW, Sajuthi S, Divers J, Parekh RS, Li M, Genovese G, Pollack MR, Hicks PJ, Bowden DW, Ma L, Freedman BI, Langefeld CD.

Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448.

10.

Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.

Cooke JN, Bostrom MA, Hicks PJ, Ng MC, Hellwege JN, Comeau ME, Divers J, Langefeld CD, Freedman BI, Bowden DW.

Nephrol Dial Transplant. 2012 Apr;27(4):1505-11. doi: 10.1093/ndt/gfr522.

11.
12.

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW.

Kidney Int. 2009 Apr;75(7):736-45. doi: 10.1038/ki.2008.701.

13.

MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS; Family Investigation of Nephropathy and Diabetes Research Group..

Nat Genet. 2008 Oct;40(10):1185-92. doi: 10.1038/ng.232.

14.

Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.

Oleksyk TK, Nelson GW, An P, Kopp JB, Winkler CA.

PLoS One. 2010 Jul 9;5(7):e11474. doi: 10.1371/journal.pone.0011474.

15.

Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.

Cooke Bailey JN, Palmer ND, Ng MC, Bonomo JA, Hicks PJ, Hester JM, Langefeld CD, Freedman BI, Bowden DW.

Hum Genet. 2014 Jun;133(6):769-79. doi: 10.1007/s00439-013-1415-z.

16.

The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.

Bonomo JA, Guan M, Ng MC, Palmer ND, Hicks PJ, Keaton JM, Lea JP, Langefeld CD, Freedman BI, Bowden DW.

Hum Mol Genet. 2014 Dec 15;23(24):6441-7. doi: 10.1093/hmg/ddu362.

17.

The MYH9/APOL1 region and chronic kidney disease in European-Americans.

O'Seaghdha CM, Parekh RS, Hwang SJ, Li M, Köttgen A, Coresh J, Yang Q, Fox CS, Kao WH.

Hum Mol Genet. 2011 Jun 15;20(12):2450-6. doi: 10.1093/hmg/ddr118.

18.

The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study.

Franceschini N, Voruganti VS, Haack K, Almasy L, Laston S, Goring HH, Umans JG, Lee ET, Best LG, Fabsitz RR, MacCluer JW, Howard BV, North KE, Cole SA.

Hum Genet. 2010 Mar;127(3):295-301. doi: 10.1007/s00439-009-0769-8.

19.

Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa.

Matsha TE, Masconi K, Yako YY, Hassan MS, Macharia M, Erasmus RT, Kengne AP.

PLoS One. 2012;7(12):e52529. doi: 10.1371/journal.pone.0052529.

20.

Complement factor H gene associations with end-stage kidney disease in African Americans.

Bonomo JA, Palmer ND, Hicks PJ, Lea JP, Okusa MD, Langefeld CD, Bowden DW, Freedman BI.

Nephrol Dial Transplant. 2014 Jul;29(7):1409-14. doi: 10.1093/ndt/gfu036.

Items per page

Supplemental Content

Support Center